Amber Therapeutics
- Headquarters
- London
- Business Model
- B2B
- Website
- ambertherapeutics.com
- Total Funding
- $100.0M
About
Adaptive, closed-loop neuromodulation device targeting the pudendal nerve to treat mixed urinary incontinence.
Funding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account